89Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study

D. G. J. Linders, M. M. Deken,M. A. van Dam,M. N. J. M. Wasser, E. M. C. Voormolen, J. R. Kroep,G. A. M. S. van Dongen,D. Vugts,H. M. Oosterkamp,M. E. Straver, C. J. H. van de Velde, D. Cohen,P. Dibbets-Schneider,F. H. P. van Velden,L. M. Pereira Arias-Bouda,A. L. Vahrmeijer,G. J. Liefers, L. F. de Geus-Oei,D. E. Hilling

Cancers（2023）

引用 0|浏览3

暂无评分

关键词

breast cancer,human epidermal growth factor receptor 2,neoadjuvant therapy,treatment response evaluation,HER2-targeted PET/CT,surgery-free treatment strategy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要